{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T07:35:53Z","timestamp":1786779353069,"version":"build-2736575974"},"reference-count":67,"publisher":"American Society for Microbiology","issue":"16","license":[{"start":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T00:00:00Z","timestamp":1471219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["HD079327"],"award-info":[{"award-number":["HD079327"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI119196"],"award-info":[{"award-number":["AI119196"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI011002"],"award-info":[{"award-number":["AI011002"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2016,8,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Influenza A virus (IAV) infections cause major morbidity and mortality, generating an urgent need for novel antiviral therapeutics. We recently established a dual myxovirus high-throughput screening protocol that combines a fully replication-competent IAV-WSN strain and a respiratory syncytial virus reporter strain for the simultaneous identification of IAV-specific, paramyxovirus-specific, and broad-spectrum inhibitors. In the present study, this protocol was applied to a screening campaign to assess a diverse chemical library with over 142,000 entries. Focusing on IAV-specific hits, we obtained a hit rate of 0.03% after cytotoxicity testing and counterscreening. Three chemically distinct hit classes with nanomolar potency and favorable cytotoxicity profiles were selected. Time-of-addition, minigenome, and viral entry studies demonstrated that these classes block hemagglutinin (HA)-mediated membrane fusion. Antiviral activity extends to an isolate from the 2009 pandemic and, in one case, another group 1 subtype. Target identification through biolayer interferometry confirmed binding of all hit compounds to HA. Resistance profiling revealed two distinct escape mechanisms: primary resistance, associated with reduced compound binding, and secondary resistance, associated with unaltered binding. Secondary resistance was mediated, unusually, through two different pairs of cooperative mutations, each combining a mutation eliminating the membrane-proximal stalk N-glycan with a membrane-distal change in HA1 or HA2. Chemical synthesis of an analog library combined with\n            <jats:italic>in silico<\/jats:italic>\n            docking extracted a docking pose for the hit classes. Chemical interrogation spotlights IAV HA as a major druggable target for small-molecule inhibition. Our study identifies novel chemical scaffolds with high developmental potential, outlines diverse routes of IAV escape from entry inhibition, and establishes a path toward structure-aided lead development.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>IMPORTANCE<\/jats:bold>\n            This study is one of the first to apply a fully replication-competent third-generation IAV reporter strain to a large-scale high-throughput screen (HTS) drug discovery campaign, allowing multicycle infection and screening in physiologically relevant human respiratory cells. A large number of potential druggable targets was thus chemically interrogated, but mechanistic characterization, positive target identification, and resistance profiling demonstrated that three chemically promising and structurally distinct hit classes selected for further analysis all block HA-mediated membrane fusion. Viral escape from inhibition could be achieved through primary and secondary resistance mechanisms.\n            <jats:italic>In silico<\/jats:italic>\n            docking predicted compound binding to a microdomain located at the membrane-distal site of the prefusion HA stalk that was also previously suggested as a target site for chemically unrelated HA inhibitors. This study identifies an unexpected chemodominance of the HA stalk microdomain for small-molecule inhibitors in IAV inhibitor screening campaigns and highlights a novel mechanism of cooperative resistance to IAV entry blockers.\n          <\/jats:p>","DOI":"10.1128\/jvi.00898-16","type":"journal-article","created":{"date-parts":[[2016,6,2]],"date-time":"2016-06-02T04:24:32Z","timestamp":1464841472000},"page":"7368-7387","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":27,"title":["Identification and Characterization of Influenza Virus Entry Inhibitors through Dual Myxovirus High-Throughput Screening"],"prefix":"10.1128","volume":"90","author":[{"given":"Marco","family":"Weisshaar","sequence":"first","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cox","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Morehouse","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Kumar Kyasa","sequence":"additional","affiliation":[{"name":"Emory Institute for Drug Development, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Oberacker","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuli","family":"Mao","sequence":"additional","affiliation":[{"name":"Emory Institute for Drug Development, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-3710","authenticated-orcid":false,"given":"Jennifer E.","family":"Golden","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Wisconsin, Madison, WI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anice C.","family":"Lowen","sequence":"additional","affiliation":[{"name":"Department of Microbiology &amp; Immunology, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Natchus","sequence":"additional","affiliation":[{"name":"Emory Institute for Drug Development, Emory University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K.","family":"Plemper","sequence":"additional","affiliation":[{"name":"Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gheart.2014.08.004"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1353\/bhm.2002.0022"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.01.029"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00231.x"},{"key":"e_1_3_3_6_2","first-page":"95","article-title":"The 1918 flu and other influenza pandemics: \u201cover there\u201d and back again","volume":"79","author":"Reid AH","year":"1999","unstructured":"Reid AH, Taubenberger JK. 1999. The 1918 flu and other influenza pandemics: \u201cover there\u201d and back again. Lab Invest 79:95\u2013101.","journal-title":"Lab Invest"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2008.151944"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70295-X"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cms059"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0910732"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.13.1435"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1003749"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1086\/595861"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0b013e31821dce27"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.09.015"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/363418a0"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja963036t"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1985.tb04038.x"},{"key":"e_1_3_3_19_2","first-page":"119","article-title":"Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine","volume":"176","author":"Hayden FG","year":"1992","unstructured":"Hayden FG, Hay AJ. 1992. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine. Curr Top Microbiol Immunol 176:119\u2013130.","journal-title":"Curr Top Microbiol Immunol"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1216526110"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(01)00215-7"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(01)00214-5"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/4371108a"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16934-1"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152607783018736"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.8.joc60020"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/1087057113501199"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2012.236"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08760"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.07.018"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jviromet.2005.01.016"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01425-13"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature08699"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00969-13"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0914994107"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.5b00623"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.100133697"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1177\/1087057112450186"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.09.022"},{"key":"e_1_3_3_40_2","volume-title":"Assay guidance manual","author":"Dahlin JL","year":"2015","unstructured":"Dahlin JL, Baell J, Walters MA. 18 September 2015. Assay interference by chemical reactivity. In Sittampalam GS, Coussens NP, Nelson H, Arkin M, Auld D, Austin C, Bejcek B, Glicksman M, Inglese J, Iversen PW, Li Z, McGee J, McManus O, Minor L, Napper A, Peltier JM, Riss T, Trask OJ Jr, Weidner J (ed), Assay guidance manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK326709\/."},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/1087057103258285"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R110.129809"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1021\/ml200125r"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020069"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1110\/ps.8.4.921"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1021\/id500022h"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02326-15"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01225-13"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1021\/cb3006193"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-83-3-601"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm5017279"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00487-15"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2012.12.002"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.11.8808-8820.1997"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1021\/bi00063a007"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.73.1.140-151.1999"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.55.165"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0628"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9273"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0807142105"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1089\/dna.2015.2896"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1405198111"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1982"},{"key":"e_1_3_3_64_2","first-page":"1","article-title":"Structure-guided design of small-molecule therapeutics against RSV disease","volume":"2016","author":"Cox R","year":"2016","unstructured":"Cox R, Plemper RK. 2016. Structure-guided design of small-molecule therapeutics against RSV disease. Expert Opin Drug Discov 2016:1\u201314.","journal-title":"Expert Opin Drug Discov"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02430-10"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/371037a0"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.9.4456-4466.2002"},{"key":"e_1_3_3_68_2","first-page":"91","article-title":"Receptor binding and cell entry by influenza viruses","volume":"3","author":"Steinhauer DA","year":"1992","unstructured":"Steinhauer DA, Sauter NK, Skehel JJ, Wiley DC. 1992. Receptor binding and cell entry by influenza viruses. Semin Virol 3:91\u2013100.","journal-title":"Semin Virol"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00898-16","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.00898-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T14:11:28Z","timestamp":1646489488000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.00898-16"}},"subtitle":[],"editor":[{"given":"S.","family":"Schultz-Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,15]]},"references-count":67,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2016,8,15]]}},"alternative-id":["10.1128\/JVI.00898-16"],"URL":"https:\/\/doi.org\/10.1128\/jvi.00898-16","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,15]]},"assertion":[{"value":"2016-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-05-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-07-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}